{'fraction_non_alphanumeric': 0.04382929642445214, 'fraction_numerical': 0.01384083044982699, 'mean_word_length': 5.382352941176471, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The effect of plasmapheresis and deoxyspergualin or cyclophosphamide treatment on anti‐porcine Gal‐α(1,3)‐Gal antibody levels in humans

Abstract: The levels of human natural anti‐porcine antibodies were followed in six HLA‐immunized patients treated with plasmapheresis (PF) in combination with either 15‐deoxyspergualin (DSG) or cyclophosphamide (CYP). PF was carried out three times a week for 4 weeks, and DSG was administered in a dose of 5 mg/kg following every third PF. CYP was given in a daily dose of 1–1.5 mg/kg. Four patients were randomized to DSG treatment and two were given CYP. Following the last (4th) DSG infusion, all patients continued on CYP treatment. Levels of antibodies toward porcine thyroglobulin were measured in an ELISA assay; thyroglobulin carries the major target for human anti‐porcine natural antibodies, Gal‐α(1,3)‐Gal determinant.